Study of COVID-19 in kidney transplant patients
Part of Infections, Lungs & breathing clinical trials.
This study looks at what happens when people with kidney transplants get COVID-19. It may help improve how doctors monitor and manage COVID-19 in transplant recipients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have received a kidney transplant (even if you also received other organs)
- You have a positive COVID-19 test (virus test, antigen test, or antibody test)
- You are being cared for as an outpatient or in the hospital
- You are an adult or a child (all ages)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving remdesivir to kidney transplant patients who test positive for COVID-19 can prevent them from getting severely ill. It is for people who have already had at least three COVID-19 vaccine doses and are scheduled to receive a kidney transplant soon.
This study looks at how often BK virus shows up in people after a combined liver-kidney transplant. It may help the transplant team better predict and manage this virus after surgery.
This study looks at how COVID can affect the kidneys soon after infection. You may be able to participate if you recently tested positive for COVID and have not had kidney replacement treatments.
This study looks at how CMV (a common virus) affects the immune system in kidney transplant patients. It may help doctors better manage CMV after transplant and improve transplant outcomes.
This study follows people with glomerulonephritis (a kidney condition causing inflammation) who are about to receive a kidney transplant. It aims to collect information to better understand their health outcomes over time.
This study looks at how the immune system of lung transplant recipients responds to a common virus called BK virus, which can sometimes cause problems after a transplant. It aims to help doctors better understand and manage the virus in transplant patients.
Hear when a new SARS CoV 2 Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.